Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 14;18(3):10.
doi: 10.1007/s11910-018-0821-y.

Treating Immune-Related Epilepsy

Affiliations
Review

Treating Immune-Related Epilepsy

Sonal Bhatia et al. Curr Neurol Neurosci Rep. .

Abstract

Purpose of review: This review explores different treatment modalities for immune-mediated epilepsy, including epilepsy caused by autoantibodies as well as epilepsy in the context of systemic autoimmune disease.

Recent findings: Autoimmune epilepsy is an increasingly recognized entity. Conventional treatments for epilepsy, such as antiseizure medications and epilepsy surgery, are less successful in treating epilepsy caused by autoimmune disease. Immunomodulatory therapies such as corticosteroids, intravenous immunoglobulin, and plasma exchange are generally more successful in treating immune-mediated epilepsy than conventional epilepsy therapies. Autoimmune epilepsy should be considered as a possible etiology for patients with frequent seizures of unknown etiology. The response to immunotherapies is often promising, particularly in patients with antibodies to neuronal cell surface antigens.

Keywords: Autoimmune epilepsy; Encephalitis; Immunotherapy; Treatment.

PubMed Disclaimer

References

    1. Brain. 2013 Oct;136(Pt 10):3151-62 - PubMed
    1. J Immunol. 2007 May 15;178(10):6590-5 - PubMed
    1. Ann Intern Med. 1991 Nov 15;115(10):787-96 - PubMed
    1. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10 ):1167-9 - PubMed
    1. Brain. 2014 Aug;137(Pt 8):2178-92 - PubMed

Substances